Commentary on recent guidelines for treating hypertension

Archives of Medical Science

Volumn 10, Issue 6, 2014, Pages 1069-1072

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEBIVOLOL;

HUMAN; HYPERTENSION; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84920016600     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.47818     Document Type: Review

References (32)

1. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011; 57: 2037-114.
2. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.
3. Banach M, Aronow WS. Should we have any doubts about hypertension therapy in elderly patients? ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn 2011; 121: 253-8.
4. Aronow WS, Banach M. Ten most important things to learn from the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Blood Press 2012; 21: 3-5.
5. Aronow WS. What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease? Arch Med Sci 2012; 8: 399-402.
6. Banach M, Aronow WS. Blood pressure j-curve: current concepts. Curr Hypertens Rep 2012; 14: 556-66.
7. Banach M, Aronow WS. Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCFAHA expert consensus document on hypertension in the elderly. J Hum Hypertens 2012; 26: 641-3.
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
9. Aronow WS. Might losartan reduce sudden cardiac death in diabetic patients with hypertension? Lancet 2003; 362: 591-2.
10. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004; 364: 1684-9.
11. Aronow WS. Current role of beta-blockers in the treatment of hypertension. Expert Opin Pharmacother 2010; 11: 2599-607.
12. Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. Current place of beta blockers in the treatment of hypertension. Curr Vasc Pharnacol 2010; 8: 733-41.
13. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18: 308-47.
14. Law MR, Morris JK, Wald NJ. Use of BP lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
15. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219.
16. American Diabetes Association. Position statement. Standards of Medical Care in Diabetes-2013. Diabetes Care 2013; 36 (Suppl. 1): S11-66.
17. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Chapter 3. Blood pressure management in CKD ND patients without diabetes mellitus. Kidney Int Suppl. 2012; 2: 357-62.
18. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Chapter 4. Blood pressure management in CKD ND patients with diabetes mellitus. Kidney Int Suppl. 2012; 2: 363-9.
19. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-20.
20. Wright JT Jr, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med 2014; 160: 499-503.
21. Banach M, Bromfeld S, Howard G, et al. Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. Int J Cardiol 2014; 176: 219-26.
22. Banach M, Serban C, Aronow WS, et al. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014; 46: 947-61.
23. Banach M, Bromfeld S, Howard G, et al. What are the blood pressure levels associated with the lowest stroke rates in the elderly? fndings from the Reasons for Geographic and Racial diferences in stroke (REGARDS) cohort study. Stroke 2014; 44 (Suppl.): ATPM99.
24. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294: 466-72.
25. Agodoa LY, Appel L, Bakris GL, et al. Efect of ramipril vs amlodipine on renal outcomes in hypertensive ne-phrosclerosis. A randomized controlled trial. JAMA 2001; 285: 2719-28.
26. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59.
27. Malyszko J, Muntner P, Rysz J, Banach M. Blood pressure levels and stroke: J-curve phenomenon. Curr Hypertens Rep 2013; 15: 575-81.
28. Banach M, Michalska M, Kjeldsen SE, et al. What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist? Expert Opin Pharmacother 2011; 12: 1835-44.
29. Krzysztoszek J, Wierzejska E, Paczkowska A, Ratajczak P. Health related behaviours and hypertension prevention in Poland. An environmental study. Arch Med Sci 2013; 9: 218-29.
30. Chiquete E, Ocho-Guzman A, Vargas-Sanchez A, et al. Blood pressure at hospital admission and outcome after primary intracerebral hemorrhage. Arch Med Sci 2013; 9: 34-9.
31. Schmieder RE, Redon J, Grassi G, et al. ESH position paper: renal denervation: an interventional therapy of resistant hypertension. J Hypertens 2012; 30: 837-41.
32. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 393-401.